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Abstract
Background: This cross-sectional study objects to measure, subjectively and objectively, the voice and life quality
of patients with oral cavity, pharyngeal and laryngeal cancer, after organ-preservation treatment.
Methods: 25 cases diagnosed and treated at a high complexity oncology center in southeastern Brazil. All had oral
cavity, pharyngeal or laryngeal cancer, with a therapeutic proposal of radiotherapy alone or simultaneous
radiochemotherapy. Acoustic voice analysis and the Voice Handicap Index protocol were used to measure voice
quality. The data were analyzed through the c2, Student’s t and Kruskal Wallis tests. Significance level was 5%.
Results: After treatment, 40% complained of hoarseness, 56% complained of throat clearing, and no patient
reported aphonia. On the voice quality auditory scale, 36% had moderate dysphonia. Acoustic voice analysis
ranged from 184 to 221 Hz in females, and from 92 to 241 Hz in males. As for quality of life, most patients had
mild physical, functional and emotional handicaps.
Conclusions: Chemio-radiation organ preservation protocols in the patients studied may leave the organ but with
reduced function which brings communication sequelae. In such cases, voice assessment and quality of life
protocols, as well as speech therapy rehabilitation, are important tools to preserve function, measure and treat
alterations, and reintegrate patients into the community.
Background
Because several sequelae of oral communication may
occur after treatment of head and neck cancer, research
in this area is important to better describe the symp-
toms and adequately control the treated patients [1].
Costa Bandeira et al. [2], studying the quality of life and
communication, voice and swallowing alterations of
radiotherapy-treated tongue cancer patients, found voice
and swallowing alterations and low quality of life scores
after 1 year, stating the important role played by the
speech therapist in the radiotherapy team.
This study aimed to analyze the voice pattern, through
subjective and objective measurements, and the quality
of life of head and neck cancer patients submitted to an
organ-preservation protocol. The Voice Handicap Index
(VHI) was used to measure voice quality [3].
Methods
Study population
The study was undertaken in the city of Juiz de Fora
(Minas Gerais state), a reference for health care in
southeastern Brazil, with an estimated population of
517,029 inhabitants [4].
It was a cross-sectional study, enrolling subjects diag-
nosed and treated at the Radiotherapy Division of a high
complexity oncology center, during the period 2000-2006.
Subjects with stages T1, T2, T3 or T4 oral cavity, phar-
yngeal or laryngeal cancer, diagnosed and treated in the
aforementioned institution, with a curative or palliative
therapeutic proposal of radiotherapy alone or simulta-
neous radiochemotherapy, were included in the study. T4
patients were enrolled if they had declined surgery.
Exclusion criteria were: death occurring previous to the
study period; surgery (alone or in combination with other
therapy) for head and neck cancer; story of previous neu-
rological alteration (due to a possible interference with
laryngeal physiology); physical, motor or emotional disor-
der precluding participation; and refusal to participate.
Figure 1 shows a flowchart for patient selection.
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The 25 patients included were submitted to focused
interview, voice assessment (acoustic and auditory-per-
ceptual analyses) and assessment of the VHI. All stages
of voice assessment and interview were performed in a
room of the local speech therapy service, by one specifi-
cally trained examiner.
Voice analysis was performed according to the para-
m e t e r sa n dm e t h o dp r o p o s e db yR e h d e ra n dB e h l a u
[5]. For auditory-perceptual analysis of oral communi-
cation, we recorded a voice sample consisting of sus-
tained emissions of the/e/vowel at standard pitch and
intensity, and performed other tests of voice content.
The recordings were made with a professional micro-
phone fitted to a portable microcomputer. The sub-
jects were assessed in the standing position, with the
upper limbs extended along the body, and at a 15 cm
mouth-microphone distance. 3 speech therapists, spe-
cialized in voice, and with over 3 years’ experience of
voice assessment, analyzed the auditory-perceptual
parameters. The GIRBAS scale (G = dysphonia global
grade, I = instability, R = roughness, B = breathiness,
A = asthenia, S = strain) was used for auditory assess-
ment of voice quality.
For the computerized acoustic assessment of voice
sounds, the Vox Metria software was used, with the
same method employed for the recording of the voice
samples for the auditory-perceptual analysis. The funda-
mental frequency (f0) and the glottal-to-noise excitation
ratio (GNE) were the measures considered for this ana-
lysis [6].
For the assessment of voice handicap, the VHI ques-
tionnaire was used, according to Moerman et al [7].
Statistical Analysis
The data were analyzed through the c
2 test with the
SPSS 15.0 software [8]. Continuous variables had their
means calculated, and were aligned and analyzed
through Student’s t test. Comparison of ordinal variables
(quality of life and voice quality scales) with nominal
outcomes (type of treatment, sex, tumor site) was made
through Kruskal Wallis’s test. Statistical significance was
set at 5%.
The study met the guidelines of the Helsinki Declara-
tion and the 196/96 Resolution of the Brazilian National
Health Council [9].
Results
Table 1 shows the sociodemographic, lifestyle and occu-
pational features of the sample.
Table 2 shows tumor characterization and therapeutic
approach.
The acoustic and auditory parameters of voice quality
are shown in table 3.
Figure 1 Study flowchart. Figure 1 shows a flowchart for patient selection. Its source is research data.
Table 1 Head and neck cancer - sample characterization,
Brazil, 2009.
SAMPLE CHARACTERIZATION
Variable Frequency
Smoking
Yes
Present 4 16%
Former 16 64%
No 5 20%
Daily use 15 cigarettes/day
Alcohol use
Yes
Present 11 44%
Former 8 32%
No 6 24%
Daily intake 4 doses
Source: Research data.
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(singing or speech). Yet 36% reported voice use in the
working environment and 84% in daily life conversation.
During the study period, the following frequencies
referred to the year of diagnosis/treatment: 8% (2000);
20% (2002); 12% (2003); 20% (2004); 12% (2005); and
28% (2006). Our sample had no case referring to the
year 2001.
79% of the subjects complained of hoarseness preced-
ing their diagnosis. After radiotherapy, the patients com-
plained of: throat clearing (56%), hoarseness (40%),
hearing impairment (40%), and fatigue and vocal effort
(8%). No patient reported aphony. As for vocal symp-
toms grading, 42.9% had grade I dysphonia and 47.6%
had grade II dysphonia. The most frequent resonance
type was laryngeal (56%). In spite of the large number of
communication complaints, only 32% were referred to
speech therapy.
Table 3 shows the vocal characterization of the 25
subjects who underwent organ preservation protocols.
On bivariate analysis, there was no association
between acoustic analysis and sex (p = 0.385), or
between acoustic analysis and GIRBAS scale (p = 0.391).
GIRBAS worsened according to anatomical location (p
= 0.002) and year of treatment (p = 0.017), and speech
therapy increased the likelihood of GIRBAS = 1 (p =
0.048). It is noteworthy that implementation of speech
therapy was influenced by sex (p = 0.057).
The main results of VHI indicated that the quality of
life showed mild physical, functional and emotional
handicaps. As for difficul t yt ob eu n d e r s t o o d ,8 0 %
reported moderate difficulty, and 12% always or almost
always had to repeat what they had just said, in order
to be understood. Notwithstanding, 64% considered
themselves talkative or extremely talkative. 40% con-
sidered their voices to have a rough pitch, 24% found
their voices to be unpredictably clear, and 12% always
or almost always had to make an effort to speak. In
20% the voice disappeared halfway through conversa-
tion, 8% felt embarrassed when speaking, and 8%
always or almost always felt incompetent when
speaking.
Table 2 Tumor characterization and therapeutic
approach, Brazil, 2009.
TUMOR CHARACTERIZATION
Variable Frequency
Histopathology
Squamous cell carcinoma 19 76%
Other types 6 24%
UICC Stage
I6 2 4
II 8 32
III 6 24
IV 5 20
Tumor site
Mouth 3 12%
Pharynx 7 28%
Oropharynx 3 12%
Nasopharynx 1 4%
Hypopharynx 3 12%
Larynx 15
Glottis 12 48%
Supraglottic 3 12%
Therapy
Radiotherapy 11 44%
Radiochemotherapy 14 56%
Treatment
Curative 22 88%
Palliative 3 12%
Neck emptying
Yes
Unilateral 6 24%
No 19 76%
UIIC - Universal Integrated Circuit Card.
Source: Research data.
Table 3 Acoustic and auditory analysis parameters,
Brazil, 2009.
ACOUSTIC AND AUDITORY ANALYSIS PARAMETERS
Variable Frequency
Auditory analysis of voice quality
Hoarse 19 76%
Hoarse-breathing 3 12%
Rough 5 20%
Crepitating 4 16%
GIRBAS
Normal 6 24%
Mild 10 40%
Moderate 9 36%
Acoustic analysis of voice quality
Fundamental frequency
Females 184 221 Hz
Males 92 241 Hz
GNE
<50 2 8%
51 - 60 1 4%
61 - 70 3 12%
71 - 80 7 28%
81 - 90 8 32%
91 - 100 4 16%
GIRBAS - (G = dysphonia global grade, I = instability, R = roughness, B =
breathiness, A = asthenia, S = strain); GNE - Glottal-to-noise excitation ratio.
Source: Research data.
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According to epidemiological data, age is one of the
main risk factors for cancer development, a finding that
points to an increase in cancer incidence with gains in
life expectancy. 76% of our patients were males, with
mean age of 64 years. Besides genetic factors, smoking
and alcohol use increase the chances of head and neck
cancer, with squamous cell carcinoma as the predomi-
nant histological type. In our sample, 64% were former
smokers and 32% former alcohol users, with 44% pre-
sent alcohol users. Mean alcohol and tobacco use time
was 40 years, with 4 doses and 15 cigarettes a day, on
average.
Recent studies have shown good results with organ
preservation approaches that use radiochemotherapy.
Although survival time is not affected, laryngeal function
is not always preserved, as state Hirsch et al [10]. In our
study, radiochemotherapy was used in 56% of the sub-
jects, followed by radiotherapy alone in 44%. A 7000 Gy
dose was applied to 64%, with a 5000 Gy fossa dose in
81%. Treatment was curative in 88%.
We chose to use a combination of objective and sub-
jective measurements, according to Leeper et al [11].
Those authors concluded that, although subjective mea-
surements of voice quality are important, objective mea-
surements are necessary to assess subtle voice changes
with time.
According to Behrman, Abramson and Myssiorek [12],
80% of prospectively studied patients had changes in
their voice quality 1 year after radiotherapy. 40% of our
patients still complained of hoarseness, and 56% of
throat clearing, even 3 years after treatment.
Carrara-de Angelis et al. [13] concluded that of 15
patients who had received radiochemotherapy for laryn-
geal cancer, 33% had adequate voice quality or mild dys-
phonia, 40% moderate dysphonia, and 27% severe
dysphonia. In a study of patients treated for glottic
tumor, Caminero et al. [14] reported that 11% had nor-
mal voices, 44% had mild dysphonia, 28% had moderate
dysphonia, and 17% had severe dysphonia. Those
authors also reported VHI results that were close to
normal. Our results were slightly better, with the follow-
ing characteristic voices: hoarse (76%), hoarse-breathing
(12%), rough (20%), and crepitating (16%). On the GIR-
BAS scale, 24% had normal voice, 40% mild dysphonia,
and 36% moderate dysphonia.
Our study showed that although most subjects had
mild physical, functional and emotional handicaps, sev-
eral aspects of communication were impaired.
The communication problems identified in our study
were: moderate difficulty to be understood, need to
repeat what had been said, poor voice quality, need to
make an effort to speak, and difficulty to socialize
(embarrassment to speak and feeling of incompetence
when speaking).
Voice quality was associated with speech rehabilitation
in our study. The same finding was reported by Van
Gogh et al. [15], who concluded that speech therapy
was effective for patients complaining of voice impair-
ment after treatment for early glottic carcinoma.
Improvement was significant with VHI analysis, and was
also confirmed through the objective voice parameters
assessed.
Conclusions
Our study results cannot be generalized, because of the
small number of patients meeting the inclusion criteria
and a possible survival bias that may have overestimated
the perception of voice and quality of life. Yet our
results suggest an important reflection on radiotherapy
and its sequelae. Communication and quality of life
after treatment for head and neck cancer are an impor-
tant issue, once longer survival should assume satisfac-
tory community interaction.
Our findings revealed that even after years of cancer
treatment completion, there remain voice symptoms
able to interfere with the quality of life. Chemio-radia-
tion organ preservation protocols in the patients studied
may leave the organ but with reduced function. There-
fore, the integration of the speech therapist in the head
and neck cancer treatment teams should bring techni-
ques that will ease patient communication.
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